India now after the horrific havoc of corona virus Black fungus Is struggling with the name disease. There is a severe shortage of medicines for the treatment of this disease in many states including Delhi. Meanwhile, America has once again extended a helping hand to India to overcome the shortage of medicine. The US-based pharmaceutical company Gilead Sciences and Mylan will send a total of 1 million doses of Ambisome (amphotericin B injection), an important anti-fungal drug used in the treatment of black fungus. Out of these,
2 lakh doses have reached India so far
India’s ambassador to the US Taranjit Singh Sandhu announced on Sunday that another consignment of AmBisome (amphotericin B injection), an important anti-fungal drug used in the treatment of black fungus, has reached India. Sandhu said that a total of 200,000 doses have been delivered so far. The remaining doses will also be supplied soon.
Indian Embassy in action after PM Modi’s order
Seeing the rising outbreak of black fungus in India, Prime Minister Narendra Modi directed the officials to buy liposomal amphotericin B injection from anywhere in the world. After which this injection has been procured from these two big pharmaceutical companies of America. On Friday, India received 50,000 vials of amphotericin-B from Gilead Sciences and Mylan.
Gilead Sciences will send 10 lakh doses
According to reports, Indian missions in various countries are trying to secure the supply of this life-saving medicine. It is because of his efforts that Gilead has sent life-saving drugs to India. American biopharmaceutical firm Gilead Sciences is working on accelerating the supply of liposomal amphotericin B injection (MBisome) to India. The company will supply a total of 1 million doses of AmBisome.
Indian companies are also making this drug fast
The Indian government is trying to increase domestic production of amphotericin B due to the increasing number of cases of black fungus or mucormycosis. The government has granted licenses to five drug manufacturers to produce the drug. Apart from this, five companies are already involved in its production. Lack of amphotericin B injection is affecting treatment of black fungus in many states.
Black fungus at risk in Kovid patients in India